From Microalgal Biomass to Products: Downstream Processing Technology Gaps and the Road to Commercial Diversification

Commercially mature products obtained by fractionation or extraction of phototrophic microalgal biomass remain concentrated in four categories: whole-cell Spirulina/Chlorella, C-phycocyanin, astaxanthin, and DHA-rich oils. Little diversification of these fractionated, mid-tier products has followed the decline in upstream costs. Whole-cell feed and live-culture markets, agricultural biostimulants, and fermentation-derived ingredients are commercially active but lie outside this phototrophic downstream-processing scope. Reported open-pond biomass production costs have fallen from ~US$10 kg⁻¹ in the 1990s to sub-US$1 kg⁻¹ nth-plant projections, yet no substantial product diversification has occurred. This review brings together three complementary lines of evidence: a bibliometric analysis of 1995–2025 publications showing that downstream fractionation, biorefinery, and integrated process design account for only 9.3% of food-core microalgal research; institutional surveys documenting the same four dominant categories across Europe, China, and global markets; and a meta-analysis of 53 whole-biomass cost rows from 16 techno-economic assessments. These sources indicate consistently that downstream processing is a necessary, though not sole, constraint on commercial diversification. A four-tier unit-operation roadmap is proposed-cell disruption at commodity energy cost, fractionation with functional ingredient preservation, decolorization and desalting at food-ingredient unit cost, and standardized transferable workflows-each linked to a quantitative threshold and to the product categories it would unlock. Closing the microalgal processing technology gap now depends less on demonstrating feasibility than on meeting these thresholds.